Medulloblastoma Clinical Trials

Sign-up For Updates

Trials current as of: 2022-11-30
Viewing 133 clinical trials across 213 countries:

Filter Results:


Clinical Trial
Sponsor
Country
Germany Switzerland
European Organisation for Research and Treatment of Cancer - EORTC
United States of America
Pediatric Brain Tumor Consortium
Canada
British Columbia Cancer Agency

DOTATOC PET/CT for Imaging NET Patients
Last Updated: 2022-11-02
Originally Posted: 2018-06-08

United States of America
St. Jude Children's Research Hospital
India
Tata Memorial Centre
United States of America
National Cancer Institute (NCI)

Volitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors
Last Updated: 2022-10-19
Originally Posted: 2018-07-24

United States of America
Valent Technologies, LLC
United States of America
University of California, San Francisco
United States of America
University of California, San Francisco
United States of America
National Institutes of Health Clinical Center (CC)
United States of America
Weill Medical College of Cornell University
United States of America
Augusta University
Australia Canada
The Hospital for Sick Children
United States of America
Pediatric Brain Tumor Consortium

131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma
Last Updated: 2022-08-25
Originally Posted: 2021-02-03

Austria Czech Republic Denmark France Norway Spain Sweden United States of America
Medical University of Vienna
United States of America
M.D. Anderson Cancer Center
United States of America
The University of Texas Health Science Center, Houston
United States of America
St. Jude Children's Research Hospital
United States of America
Pediatric Brain Tumor Consortium

Phase I Study of APX005M in Pediatric CNS Tumors
Last Updated: 2022-08-08
Originally Posted: 2017-12-15

United States of America
Wake Forest University Health Sciences
United States of America
University of Alabama at Birmingham

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Last Updated: 2022-07-28
Originally Posted: 2019-04-09

United States of America
Emory University

AflacST1901: Peds WP1066
Last Updated: 2022-07-24
Originally Posted: 2020-04-02

United States of America
National Institutes of Health Clinical Center (CC)

Rare CNS Tumors Outcomes &Risk
Last Updated: 2022-07-06
Originally Posted: 2017-08-15

United States of America
St. Jude Children's Research Hospital

Methionine PET/CT Studies In Patients With Cancer
Last Updated: 2022-07-05
Originally Posted: 2009-02-09

Switzerland United States of America
University of California, San Francisco

Fimepinostat in Treating Brain Tumors in Children and Young Adults
Last Updated: 2022-07-05
Originally Posted: 2019-03-26

United States of America
The University of Texas Health Science Center, Houston
United States of America
Duke University

PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma
Last Updated: 2022-06-07
Originally Posted: 2017-09-27

Australia Canada New Zealand United States of America
St. Jude Children's Research Hospital

A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
Last Updated: 2022-05-13
Originally Posted: 2013-06-10

United States of America
Washington University School of Medicine

Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors
Last Updated: 2022-04-19
Originally Posted: 2012-07-30

United States of America
Masonic Cancer Center, University of Minnesota

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
Last Updated: 2022-04-11
Originally Posted: 2012-01-04

United States of America
St. Jude Children's Research Hospital

Study of Stored Tumor Samples in Young Patients With Brain Tumors
Last Updated: 2022-04-05
Originally Posted: 2009-05-09

Denmark Netherlands Spain United Kingdom United States of America
Y-mAbs Therapeutics

177Lu-DTPA-Omburtamab Radioimmunotherapy for Recurrent or Refractory Medulloblastoma
Last Updated: 2022-03-23
Originally Posted: 2019-11-11

United States of America
Augusta University
United States of America
Chimerix
United States of America
Nationwide Children's Hospital
Canada New Zealand United States of America
Nationwide Children's Hospital
China
Beijing Sanbo Brain Hospital
United States of America
Seattle Children's Hospital
United States of America
Seattle Children's Hospital
Canada United States of America
Dana-Farber Cancer Institute
Sweden
University of Birmingham
China
Fudan University

NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
Last Updated: 2021-11-20
Originally Posted: 2021-11-05

United States of America
Cedars-Sinai Medical Center
Italy
EORTC AISBL/IVZW
Germany
European Organisation for Research and Treatment of
Egypt
Cairo University
Netherlands
University of Birmingham
United States of America
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Norway
University of Birmingham
Italy
UNIVERSITY OF BIRMINGHAM
Denmark
University of Birmingham
Egypt
Children's Cancer Hospital Egypt 57357

Dual Task Training On Children With Ataxia After Medulloblastoma Resection
Last Updated: 2021-04-22
Originally Posted: 2021-03-21

United States of America
Istari Oncology, Inc.

Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children
Last Updated: 2021-03-23
Originally Posted: 2017-02-02

France
University Hospital, Angers
Egypt
Children's Cancer Hospital Egypt 57357
China
Guangdong Zhongsheng Pharmaceutical Co., Ltd.

A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors
Last Updated: 2020-07-20
Originally Posted: 2018-11-05

Canada United States of America
National Cancer Institute (NCI)
United States of America
Oncurious NV

A Study of TB-403 in Pediatric Subjects With Relapsed or Refractory Medulloblastoma
Last Updated: 2020-04-01
Originally Posted: 2016-04-08

United States of America
M.D. Anderson Cancer Center
United States of America
St. Jude Children's Research Hospital

Components of Social Functioning in Survivors of Pediatric Brain Tumors
Last Updated: 2020-01-17
Originally Posted: 2017-11-28

United States of America
University of Iowa
Australia
Dr. David Ziegler
Spain
Medizinische Universität Wien, Universitätsklinik für Kinder- und Jugendheilkunde
China
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Study of Tomotherapy HD in Medulloblastoma
Last Updated: 2018-09-16
Originally Posted: 2018-09-16

France
Central Hospital, Nancy, France
Germany
Universitätsklinikum Hamburg-Eppendorf

International HIT-MED Registry (I-HIT-MED)
Last Updated: 2017-10-17
Originally Posted: 2015-02-04

Austria Belgium Czech Republic Denmark France Germany Ireland Italy Netherlands Norway Poland Portugal Spain Sweden Switzerland United Kingdom
Universitätsklinikum Hamburg-Eppendorf

International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma
Last Updated: 2017-05-05
Originally Posted: 2014-02-07

France
Gustave Roussy, Cancer Campus, Grand Paris
Denmark
Medizinische Universität Wien, Universitätsklinik für Kinder- und Jugendheilkunde
Czech Republic
Medizinische Universität Wien, Universitätsklinik für Kinder- und Jugendheilkunde
Sweden
Medizinische Universität Wien, Universitätsklinik für Kinder- und Jugendheilkunde
France
Institut de cancérologie Gustave Roussy
Austria
Medizinische Universität Wien, Universitätsklinik für Kinder- und Jugendheilkunde

Sign-Up For Updates

* indicates required
BETA: Clinical Trial Updates (When They Become Available)
General Updates